Ubiquitin and ubiquitin-like proteins as multifunctional signals

Nature Reviews Molecular Cell Biology

Volumn 6, Issue 8, 2005, Pages 599-609

  Welchman, Rebecca L ^a   Gordon, Colin ^b   Mayer, R John ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; CONCANAVALIN A; FAU UBIQUITIN LIKE PROTEIN 1; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NEDD8 PROTEIN; PROTEASOME; PROTEIN ATG12; PROTEIN ATG8; PROTEIN FAT10; PROTEIN MAD2; PROTEIN P53; PROTEIN UBIQUITIN RELATED MODIFIER 1; SUMO PROTEIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; UBIQUITIN; UBIQUITIN CROSS REACTIVE PROTEIN; UBIQUITIN LIKE PROTEIN 5; UBIQUITIN PROTEIN LIGASE; UBIQUITON; UNCLASSIFIED DRUG;

AUTOPHAGY; CELL ACTIVITY; CELL SELECTION; COVALENT BOND; DNA REPAIR; ENDOCYTOSIS; GENETIC TRANSCRIPTION; HUMAN; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN TARGETING; REVIEW; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; SRC HOMOLOGY DOMAIN; UBIQUITINATION;

ANIMALS; HUMANS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN PROCESSING, POST-TRANSLATIONAL; SIGNAL TRANSDUCTION; UBIQUITIN; UBIQUITINS;

EID: 23144449208     PISSN: 14710072     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrm1700     Document Type: Review

References (131)

1. Mayer, R. J. The Nobel Prize for Chemistry 2004. European Biopharm. Rev. (in the press).
2. Glickman, M. H. & Ciechanover, A. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol. Rev. 82, 373-428 (2002).
3. Hershko, A., Heller, H., Elias, S. & Ciechanover, A. Components of ubiquitin-protein ligase system. Resolution, affinity purification, and role in protein breakdown. J. Biol. Chem. 258, 8206-8214 (1983).
4. Koegl, M. et al. A novel ubiquitination factor, E4, is involved in multiubiquitin chain assembly. Cell 96, 635-644 (1999).
5. Thrower, J. S., Hoffman, L., Rechsteiner, M. & Pickart, C. M. Recognition of the pdyubiquitin proteolytic signal. EMBO J. 19, 94-102 (2000).
6. Wilkinson, K. D. Ubiquitination and deubiquitination: targeting of proteins for degradation by the proteasome. Semin. Cell Dev. Biol. 11, 141-148 (2000).
7. Lake, M. W., Wuebbens, M. M., Rajagopalan, K. V. & Schindelin, H. Mechanism of ubiquitin activation revealed by the structure of a bacterial MoeB-MoaD complex. Nature 414, 326-329 (2001). The crystal structure of the prokaryotic MoeB-MoaD complex provides a molecular framework for understanding the activation of ubiquitin, NEDD8 and SUMO.
8. Rudolph, M. J., Wuebbens, M. M., Rajagopalan, K. V. & Schindelin. H. Crystal structure of molybdoptehn synthase and its evolutionary relationship to ubiquitin activation. Nature Struct. Biol. 8, 42-46 (2001).
9. Wang, C., Xi, J., Begley, T. R & Nicholson, L. K. Solution structure of ThiS and implications for the evolutionary roots of ubiquitin. Nature Struct. Biol. 8, 47-51 (2001).
10. Bienkowska, J. R., Hartman, H. & Smith, T. F. A search for homologs of small proteins. Ubiquitin-like proteins in prokaryotic cells? Protein Engin. 16, 897-904 (2003).
11. Lorick, K. L., Tsai, Y-C., Yang, Y. & Weissman, A. in Protein Degradation 1st edn Vol. 1 Ch. 4 (eds Mayer, R. J., Ciechanover, A. & Rechsteiner, M.) 44-101 (Wiley-VCH, Weinheim, Germany, 2005).
12. Schwartz, D. C. & Hochstrasser, M. A superfamily of protein tags: ubiquitin, SUMO and related modifiers. Trends Biochem. Sci. 28, 321-328 (2003).
13. Wilkinson, K. D. Roles of ubiquitinylation in proteolysis and cellular regulation. Annu. Rev. Nutr. 15, 161-189 (1995).
14. Peng, J. et al. A proteomic approach to understanding protein ubiquitination. Nature Biotech. 21, 921-926 (2003).
15. Prakash, S., Sung, P. & Prakash, L. DNA repair genes and proteins of Saccharomyces cerevisiae. Annu. Rev. Genet. 27, 33-70 (1993).
16. Hoege, C., Pfander, B., Moldevan, G. L. Pyrowolakis, G. & Jentsch, S. RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO. Nature 12, 135-141 (2002). Modification by SUMO and ubiquitin differentially affect resistance to DNA damage, and the damage-induced ublqultylation of PCNA is essential for DNA repair and occurs on the same conserved residue in yeast and humans.
17. Stelter, P. & Ulrich, H. D. Control of spontaneous and damage-induced mutagenesis by SUMO and ubiquitin conjugation. Nature 425, 188-191 (2003).
18. Haracska, L., Torres-Ramos, C. A., Johnson, R. E., Prakash, S. & Prakash, L. Opposing effects of ubiquitin conjugation and SUMO modification of PCNA on replicational bypass of DNA lesions in Saccharomyces cerevisiae. Mol. Cell. Biol. 24, 4267-1274 (2004).
19. Sun, Z. W. & Allis, C. D. Ubiquitination of histone H2B regulates H3 methylation and gene silencing in yeast. Natures, 104-108 (2002). This work shows that the ubiquitylation of H2B regulates H3 methylation and gene silencing.
20. Pray-Grant, M. G., Daniel, J. A., Schielte, D., Yates, J. R. III & Grant, P. A. Chd1 chromodomain links histone H3 methylation with SAGA-and SLIK-dependent acetylation. Nature 433, 434-438 (2005).
21. Wang, H. et al. Role of histone H2A ubiquitination in Polycomb silencing. Nature 431, 873-878 (2004).
22. Gonzalez, F., Delahodde, A., Kodadek, T. & Johnston, S. A. Recruitment of a 19S proteasome subcomplex to an activated promoter. Science 296, 648-550 (2002).
23. Gillette, T. G., Gonzalez, F., Delahodde, A., Johnston, S. A. & Kodadek, T. Physical and functional association of RNA polymerase II and the proteasome. Proc. Natl Acad. Sci. USA 101, 5904-5909 (2004).
24. Muratani, M., Kung, C., Shokat, K. M. & Tansey, W. P. The F box protein Dsg1/Mdm30 is a transcriptional coactivator that stimulates Gal4 turnover and cotranscriptional mRNA processing. Cell 120, 887-899 (2005).
25. Reid, G. et al. Cyclic, proteasome-mediated turnover of unliganded and liganded ERa on responsive promoters is an integral feature of estrogen signalling. Mol. Cell 11, 695-707 (2003).
26. Rodriguez, M. S. et al. SUMO-1 modification activates the transcriptional response of p53. EMBO J. 18, 6455-6461 (1999).
27. Xirodimas, D. P., Seville, M. K., Bourdon, J. C., Hay, R. T. & Une, D. P. Mdm2-mediated NEDD8 conjugation of p53 inhibits is transcriptional actwity. Cell 118, 83-97 (2004).
28. Meylan, E. & Tschopp, J. The RIP kinases: crucial integrators of cellular stress. Trends Biochem. Sci. 30, 151-159 (2005).
29. Sun, L. & Chen, Z. J. The novel functions of ubiquitination in signaling. Curr. Opin. Cell. Biol. 16, 119-126 (2004).
30. Kanayama, A. et al. TAB2 and TABS activate the NF-κB pathway through binding to polyubiquitin chains. Mol. Cell 15, 535-548 (2004).
31. Ravid, T. & Hochstrasser, M. NF-κB signalling: flipping the switch with polyubiquitin chains. Curr. Biol. 14, R898-R900 (2004).
32. Wilkinson, K. D. Signal transduction: aspirin, ubiquitin and cancer. Nature 424, 738-739 (2003).
33. Wertz, I. E. et al. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling. Nature 430, 694-699 (2004). The first example of a protein that contains separate ubiquitin-ligase and deubiquitylating domains, which both participate in a single regulatory pathway.
34. Laurin, N., Brown, J. P., Morissette, J. & Raymond, V. Recurrent mutation of the gene encoding sequestosome 1 (SQSTM/P62) in Paget disease of bone. Am. J. Hum. Genet. 70, 1582-1588 (2002).
35. Hocking, L. J. et al. Domain-specific mutations in sequestosome 1 (SQSTM1) cause familial and sporadic Paget's disease. Hum. Mol. Genet. 11, 2735-2739 (2002).
36. Duran, A. et al. The atypical PKC-interacting protein p62 is an important mediator of RANK-activated osteoclastogenesis. Dev. Cell 6, 303-309 (2004).
37. Cavey, J. R. et al. Loss of ubiquitin-binding associated with Paget's disease of bone p62 (SQSTM1) mutations. J. Bone Miner. Res. 20, 619-624 (2005).
38. Katzmann, D. J., Odorizzi, G. & Emr, S. D. Receptor downregulation and multivesicular-body sorting. Nature Rev. Mol. Cell Biol. 3, 893-905 (2002).
39. Haglund, K. et al. Multiple monoubiquitylation of RTKs is sufficient for their endocytosis and degradation. Nature Cell Biol. 5, 461-166 (2003).
40. Terrell, J., Shin, S., Dunn, R. & Hicke, L. A function for monoubiquitination in the internalization of a G protein-coupled receptor. Mol. Cell 1, 193-202 (1998). This paper shows that monoubiquitylation on a single lysine residue is sufficient to signal receptor internalization.
41. Galan, J. M. & Haguenauer-Tsapis, R. Ubiquitin Lys63 is involved in ubiquitination of a yeast plasma membrane protein. EMBO J. 16, 5847-5854 (1997).
42. 4-induced down-regulation of the Saccharomyces cerevisiae Gap1 p permease involves its ubiquitination with lysine-63-linked chains. J. Cell Sci. 112, 1375-1383 (1999).
43. Hicke, L., Schubert, H. L. & Hill, C. P. Ubiquitin-binding domains. Nature Rev. Mol. Cell Biol. 6, 610-621 (2005).
44. Kotaja, N., Karvonen, U., Janne, O. A. & Palvimo, J. J. PIAS proteins modulate transcription factors by functioning as SUMO-1 ligases. Mol. Cell. Biol. 22, 5222-5234 (2002).
45. Hori, T. et al. Covalent modification of all members of human cullin family proteins by NEDD8. Oncogene 18, 6829-6834 (1999).
46. Cope, G. A. & Deshaies, R. J. COP9 signalosome: a multifunctional regulator of SCF and other cullin-based ubiquitin ligases. Cell 114, 663-671 (2003).
47. Gill, G. SUMO and ubiquitin in the nucleus: different functions, similar mechanisms? Genes Dev. 18, 2046-2059 (2004).
48. Tatham, M. H. et al. Polymeric chains of SUMO-2 and SUMO-3 are conjugated to protein substrates by SAE1/ SAE2 and Ubc9. J. Biol. Chem. 276, 35368-35374 (2001).
49. Bylebyl, G. R., Belichenko, I. & Johnson, E. S. The SUMO isopeptidase Ulp2 prevents accumulation of SUMO chains in yeast. J. Biol. Chem. 278, 44113-44120 (2003).
50. Matunis, M. J., Coutavas, E. & Blobel, G. A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear pore complex. J. Cell Biol. 135, 1457-1470 (1996). The first cellular target of SUMO modification is identified.
51. Eaton, E. M. & Sealy, L. Modification of CCAAT/enhancer binding protein-β by the small ubiquitin-like modifier (SUMO) family members, SUMO-2 and SUMO-3. J. Biol. Chem. 278, 33416-33421 (2003).
52. Azuma, Y., Arnaoutov, A. & Dasso, M. SUMO-2/3 regulates topoisomerase II in mitosis. J. Cell Biol. 163, 477-487 (2003).
53. Zhao, C. et al. The UbcH8 ubiquitin E2 enzyme is also the E2 enzyme for ISG15, an IFN-α/β-induced ubiquitin-like protein. Proc. Natl Acad. Sci. USA 101, 7578-7582 (2004).
54. D'Cunha, J. et al. In vitro and in vivo secretion of human ISG15, an IFN-induced immunomodulatory cytokine. J. Immunol. 157, 4100-4108 (1996).
55. Malakhov, M. P. et al. High-throughput immunoblotting. Ubiquitiin-like protein ISG15 modifies key regulators of signal transduction. J. Biol. Chem. 278, 16608-16613 (2003).
56. Hamerman, J. A. et al. Serpin 2a is induced in activated macrophages and conjugates to a ubiquitin homolog. J. Immunol. 168, 2415-2423 (2002).
57. Raasi, S., Schmidtke, G., de Giuli, R. & Groettrup, M. A ubiquitin-like protein which is syhergistically inducible by interferon-γ and tumor necrosis factor-α. Eur. J. Immunol. 29, 4030-4036 (1999).
58. Bates, E. E. et al. Identification and analysis of a novel member of the ubiquitin family expressed in dendritic cells and mature B cells. Eur. J. Immunol. 27, 2471-2477 (1997).
59. Liu, Y. C. et al. A MHC-encoded ubiquitin-like protein (FAT10) binds noncovalently to the spindle assembly checkpoint protein MAD2. Proc. Natl Acad. Sci. USA 96, 4313-4318 (1999).
60. Lee, C.G. et al. Expression of the FAT10 gene is highly upregulated in hepatocellular carcinoma and other gastrointestinal and gynecological cancers. Oncogene 22, 2592-2603 (2003).
61. Raasi, S., Schmidtke, G. & Groettrup, M. The ubiquitin-like protein FAT10 forms covalent conjugates and induces apoptosis. J. Biol. Chem. 276, 35334-35343 (2001).
62. Hipp, M.S., Raasi, S., Groettrup, M. & Schmidtke, G. NEDD8 ultimate buster-1L interacts with the ubiquitin-like protein FAT10 and accelerates its degradation. J. Biol. Chem. 279, 16503-16510 (2004).
63. Kamitani, T., Kito, K., Fukuda-Kamitani, T. & Yeh, E. T. Targeting of NEDD8 and its conjugates tor proteasomal degradation by NUB1. J. Biol. Chem. 276, 46655-46660 (2001).
64. Nakamura, M., Xavier, R. M., Tsunematsu, T. & Tanigawa, Y. Molecular cloning and characterization of a cDNA encoding monoclonal nonspecific suppressor factor. Proc. Natl Acad. Sci. USA 92, 3463-3467 (1995).
65. Nagata, T., Nakamura, M., Kawauchi, H. & Tanigawa, Y. Conjugation of ubiquitin-like polypeptide to intracellular acceptor proteins. Biochim. Biophys. Acta 1401, 319-328 (1998).
66. Nakamura, M., Tsunematsu, T. & Tanigawa, Y. Biochemical analysis of a T cell receptor α-like molecule involved in antigen-nonspecific suppression. Biochim. Biophys. Acta 1589, 196-202 (2002).
67. Nakamura, M. & Tanigawa, Y. Protein tyrosine phosphorylation induced by ubiquitin-like polypeptide in murine T helper clone type 2. Biochem. Biophys. Res. Commun. 274, 565-570 (2000).
68. Nakamura, M. & Tanigawa, Y. Characterization of ubiquitin-like polypeptide acceptor protein, a novel pro-apoptotic member of the Bcl2 family. Eur. J. Biochem. 270, 4052-4058 (2003).
69. Friedman, J. S., Koop, B. F., Raymond, V. & Walter, M. A. Isolation of a ubiquitin-like (UBL5) gene from a screen identifying highly expressed and conserved iris genes. Genomics 71, 252-255 (2001).
70. McNally, T. et al. Structural analysis of UBLS, a novel ubiquitin-like modifier. Prot. Sci. 12, 1562-1566 (2003).
71. Ramelot, T. A. et al. Solution structure of the yeast ubiquitin-like modifier protein Hub1. J. Struct. Fund. Genomics 4, 25-30 (2003).
72. Dittmar, G. A., Wilkinson, C. R., Jedrzejewski, P. T. &, Finley, D. Role of a ubiquitin-like modification in polarized morphogenesis. Science 295, 2442-2446 (2002).
73. Luders, J., Pyrowolakis, G. & Jentsch, S. The ubiquitin-like protein HUB1 forms SDS-resistant complexes with cellular proteins in the absence of ATP. EMBO Rep. 4, 1169-1174 (2003).
74. Makarova, O. V. et al. A subset of human 35S U5 proteins, including Prp19, function prior to catalytic step 1 of splicing. EMBO J. 23, 2381-2391 (2004).
75. Kantham, L. et al. Beacon interacts with cdc2/cdc28-like kinases. Biochem. Biophys. Res. Commun. 304, 125-129 (2003).
76. Wilkinson, C. R. et al. Ubiquitin-like protein Hub1 is required for pre-mRNA splicing and localization of an essential splicing factor in fission yeast. Curr. Biol. 14, 2283-2288 (2004).
77. Collier, G. R. et al. Beacon: a novel gene involved in the regulation of energy balance. Diabetes 49, 1766-1771 (2000).
78. Schwarte, M. W. & Porte, D. Diabetes, obesity, and the brain. Science 307, 375-379 (2005).
79. Furukawa, K., Mizushima, N., Noda, T. & Ohsumi, Y. A protein conjugation system in yeast with homology to biosynthetic enzyme reaction of prokaryotes. J. Biol. Chem. 275, 7462-7465 (2000).
80. Goehring, A. S., Rivers, D. M. & Sprague, G. F. Attachment of the ubiquitin-related protein Urm1 p to the antioxidant protein Ahp1 p. Eukaryot. Cell 2, 930-936 (2003).
81. Goehring, A. S., Rivers, D. M. & Sprague, G. F. Urmylation: a ubiquitin-like pathway that functions during invasive growth and budding in yeast. Mol. Biol. Cell 14, 4329-4341 (2003).
82. Chan, T. F., Carvalho, J., Riles, L. & Zheng, X. F. A chemical genomics approach toward understanding the global functions of the target of rapamycin protein (TOR) Proc. Natl Acad. Sci. USA 97, 13227-13232 (2000).
83. Cutler, N. S., Pan, X., Heitman, J. & Cardenas, M. E. The TOR signal transduction cascade controls cellular differentiation in response to nutrients. Mol. Biol. Cell 12, 4103-4113 (2001).
84. Klionsky, D.J. & Emr, S. D. Autophagy as a regulated pathway of cellular degradation. Science 290, 1717-1721 (2000).
85. Mizushima, N. et al. A protein conjugation system essential for autophagy. Nature 395, 395-398 (1998). This paper shows that autophagy is regulated by a ubiquiton.
86. Ichimura, Y. et al. A ubiquitin-like system mediates protein lipidation. Nature 408, 488-492 (2000).
87. Mizushima, N., Yoshimori, T. & Ohsumi, Y. Role of the Apg12 conjugation system in mammalian autophagy. Int. J. Biochem. Cell Biol. 35, 553-561 (2003).
88. Liang, X. H. et al. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature 402, 672-676 (1999).
89. Anglade, P. et al. Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease. Histol. Histopathol. 12, 25-31 (1997).
90. Nassar, N. et al. The 2.2 A crystal structure of the Ras-binding domain of the serine/threonine kinase c-Raf1 in complex with Rap1 A and a GTP analogue. Nature 375, 554-560 (1995). This work identifies a genetically built-in ubiquiton in a large regulatory protein.
91. Noda, Y. et al. Molecular recognition in dimerization between PB1 domains. J. Biol. Chem. 278, 43524-43524 (2003).
92. Hirano, Y. et al. Solution structure of atypical protein kinase C PB1 domain and its mode of interaction with ZIP/P62 and MEK5. J. Biol. Chem. 279, 31883-31890 (2004).
93. Cavanaugh, J. E. Role of extracellular signal kinase 5 in neuronal development. Eur. J. Biochem. 271, 2056-2059 (2004).
94. Hofmann, K. & Bucher, P. The UBA domain: a sequence motif present in multiple enzyme classes of the ubiquitination pathway. Trends Biochem. Sci. 21, 172-173 (1996). This study identifies a ubiquitin-binding domain using a bioinformatics approach.
95. Bertolaet, B. L. et al. UBA domains of DNA damage-inducible proteins interact with ubiquitin. Nature Struct. Biol. 8, 417-422 (2001).
96. Wilkinson, C. R. et al. Proteins containing the UBA domain are able to bind to multi-ubiquitin chains. Nature Cell Biol. 3, 939-943 (2001).
97. Schauber, C. et al. Rad23 links DNA repair to the ubiquitin/ proteasome pathway. Nature 391, 715-718 (1998).
98. Seeger, M. et al. Interaction of the anaphase-promoting complex/cyclosome and proteasome protein complexes with multtubiquitin chain-binding proteins. J. Biol. Chem. 278, 16791-16796 (2003).
99. Elsasser, S., Chandler-Militello, D., Muller, B., Hanna, J. & Finley, D. Rad23 and Rpn10 serve as alternative ubiquitin receptors for the proteasome. J. Biol. Chem. 279, 26817-26822 (2004).
100. Verma, R., Oania, R., Graumann, J. & Deshaies, R. J. Muftiubiquitin chain receptors define a layer of substrate selectivity in the ubiquitin-proteasome system. Cell 118, 99-110 (2004).
101. Funakoshi, M., Sasaki, T., Nishimoto, T. & Kobayashi, H. Budding yeast Dsk2p is a polyubiquitin-binding protein that can interact with the proteasome. Proc. Natl Acad. Sci. USA 99, 745-750 (2002).
102. Saeki, Y., Sone, T., Toh-e, A. & Yokosawa, H. Identification of ubiquitin-like protein-binding subunits of the 26S proteasome, Biochem. Biophys. Res. Commun. 296, 813-819 (2002).
103. Chen, L. & Madura, K. Rad23 promotes the targeting of proteolytic substrates to the proteasome. Mol. Cell. Biol. 22, 4902-4913 (2002).
104. Kim, I., Mi, K. & Rao, H. Multiple interactions of Rad23 suggest a mechanism for ubiquitylated substrate delivery important in proteolysis. Mol. Biol. Cell 15, 3357-3365 (2004).
105. Richly, H. et al. A series of ubiquitin binding factors connects CDC48/p97 to substrate multiubiquitylation and proteasomal targeting. Cell 120, 73-84 (2005). This paper identifies a series of protein-protein interactions that escort ubiquitin-protein conjugates to the proteasome.
106. Verma, R. et al. Proteasomal proteomics: identification of nucleotide-sensitive proteasome-interacting proteins by mass spectrometric analysis of affinity-purified proteasomes. Mol. Biol. Cell 11, 3425-3439 (2000).
107. Dai, R. M., Chen, E., Longo, D. L., Gorbea, C. M. & Li, C. C. Involvement of valosin-containing protein, an ATPase co-purified with 1κBα and 26 S proteasome, in ubiquitin-proteasome-mediated degradation of 1κBα. J. Biol. Chem. 273, 3562-3573 (1998).
108. Buchberger, A., Howard, M. J., Proctor, M. & Bycroft, M. The UBX domain: a widespread ubiquitin-like module. J. Mol. Biol. 307, 17-24 (2001).
109. Decottignies, A., Evain, A. & Ghislain, M. Binding of Cdc48p to a ubiquitin-related UBX domain from novel yeast proteins involved in intracellular proteolysis and sporulation. Yeast 21, 127-139 (2004).
110. Hartmann-Petersen, R. et al. The Ubx2 and Ubx3 cofactors direct Cdc48 activity to proteolytic and nonproteolytic ubiquitin-dependent processes. Curr. Biol. 14, 824-828 (2004).
111. Schuberth, C., Richly, H., Rumpf, S. & Buchberger, A. Shp1 and Ubx2 are adaptors of Cdc48 involved in ubiquitin-dependent protein degradation. EMBO Rep. 5, 818-824 (2004).
112. Com, P. G., McDonald, E. R., Herman, J. G. a El-Deiry, W. S. Tat-binding protein-1, a component of the 26S proteasome, contributes to the E3 ubiquitin ligase function of the von Hippel-Lindau protein. Nature Genet. 35, 229-237 (2003).
113. Hicke, L. & Dunn, R. Regulation of membrane protein transport by ubiquitin and ubiquitin binding proteins. Ann. Rev. Cell Dev. Biol. 19, 141-172 (2003).
114. Guarino, L. A., Smith, G. & Dong, W. Ubiquitin is attached to membranes of baculovirus particles by a novel type of phospholipid anchor. Cell 80, 301-309 (1995). This work identifies phosphatidyt-ubiquitin.
115. Webb, J. H., Mayer, R. J. & Dixon, L. K. A lipid modified ubiquitin is packaged into particles of several enveloped viruses. FEBS Lett. 444, 136-139 (1999).
116. Garrus, J. E. et al. Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell 107, 55-65 (2001).
117. Veiga, E. & Cossart, P. Ubiquitination of intracellular bacteria: a new bacteria-sensing system? Trends Cell Biol. 15, 2-5 (2005).
118. Ogawa, M. et al. Escape of intracellular Shigella from autophagy. Science 307, 727-731 (2005).
119. Orth, K. Function of the Yersinia effector YopJ. Curr. Opin. Microbiol. 5, 38-43 (2002).
120. 13C resonance assignments and secondary structure determination reveal that the minimal Rad GTPase binding domain of plexin-B1 has a ubiquitin fold. J. Biomol. NMR 31, 369-370 (2005).
121. Mayer, R. J., Landon, M. & Layfield, R. Ubiquitin superfolds: intrinsic and attachable regulators of cellular activities? Fold. Des. 3, R97-R99 (1998). These authors suggest that ubiquitin superfolds are conserved throughout evolution and can be attached to, or genetically built into, proteins.
122. Clague, W. J. Membrane transport: a coat for ubiquitin. Curr. Biol. 12, R529-R531 (2002).
123. Sachse, M., Urbz, S., Ooschot, V., Strous, G. J. & Klumperman, J. Bilayered clathrin coats on endosomal vacuoles are involved in protein sorting toward lysosomes. Mol. Biol. Cell 13, 1313-1328 (2002).
124. Pornillos, O. W. et al. HIV Gag mimics the Tsg101-recruiting activity of the human Hrs protein. J. Cell Biol. 162, 425-434 (2003).
125. Thien, C. B. F. & Langdon, W. Y. Cbl: many adaptations to regulate protein tyrosine kinases. Nature Rev. Mol. Cell Biol. 2, 294-305 (2001).
126. McCullough, J., Clague, M. J. & Urbe, S. AMSH is an endosome-associated ubiquitin isopeptidase. J. Cell Biol. 166, 487-492 (2004).
127. Amerik, A. Y., Nowak, J., Swaminathan, S. &, Hochstrasser, M. The Doa4 deubiquitinating enzyme is functionally linked to the vacuolar protein-sorting and endocytic pathways. Mol. Biol. Cell 11, 3365-3380 (2000).
128. Urbé, S. in Essays In Biochemistry Vol. 41 (eds Layfield, R. & Mayer, R. J.) (Biochemical Society, London, in the press).
129. Hartmann-Petersen, R. & Gordon, C. Integral UBL domain proteins: a family of proteasome interacting proteins. Semin. Cell Dev. Biol. 15, 247-259 (2004).
130. Sakata, E. et al. Parkin binds the Rpn10 subunit of 26S proteasomes through its ubiquitin-like domain. EMBO Rep. 4, 301-306 (2003).
131. Ciechanover, A. Proteolysis: from the lysosome to ubiquitin and the proteasome. Nature Rev. Mol. Cell Biol. 6, 79-87 (2005).